These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phase II randomized, placebo-controlled trial of M. vaccae-derived protein (PVAC) for the treatment of psoriasis. Netto EM; Takahashi D; de Fátima Paim de Oliveira M; Barbosa P; Ferraz N; Paixão A; Oyafuso LK; Bortoletto C; Matos D; Paixão M; da Silva AO; Badaro R Vaccine; 2006 Jun; 24(23):5056-63. PubMed ID: 16621200 [TBL] [Abstract][Full Text] [Related]
3. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Dalbeth N; Yeoman S; Dockerty JL; Highton J; Robinson E; Tan PL; Herman D; McQueen FM Ann Rheum Dis; 2004 Jun; 63(6):718-22. PubMed ID: 15140780 [TBL] [Abstract][Full Text] [Related]
14. A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis. Genovese MC; Chakravarty EF; Boyle DL; Tutuncu Z; Thorburn CM; Halilhodzic M; Kroll S; Baughman J; Stewart S; Kavanaugh A J Rheumatol; 2005 Dec; 32(12):2345-50. PubMed ID: 16331761 [TBL] [Abstract][Full Text] [Related]
15. A parallel phase I/II clinical trial design for combination therapies. Huang X; Biswas S; Oki Y; Issa JP; Berry DA Biometrics; 2007 Jun; 63(2):429-36. PubMed ID: 17688495 [TBL] [Abstract][Full Text] [Related]
16. Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction. Heading CE Curr Opin Investig Drugs; 2007 Jan; 8(1):71-7. PubMed ID: 17263188 [TBL] [Abstract][Full Text] [Related]